<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00773032</url>
  </required_header>
  <id_info>
    <org_study_id>071529_OA</org_study_id>
    <nct_id>NCT00773032</nct_id>
  </id_info>
  <brief_title>Age-Dependent Memory Benefits From Pharmacologically Enhanced Naps?</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Diego</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate whether

        1. pharmacologically enhanced naps will show increases in specific sleep stages

        2. whether these sleep stages will produces specific increases on memory tests

        3. whether older adults will benefit more than young adults from increased SWS or Stage 2
           on subsequent declarative and motor memory tests.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2008</start_date>
  <primary_completion_date type="Anticipated">June 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <number_of_arms>3</number_of_arms>
  <condition>Older Adults</condition>
  <arm_group>
    <arm_group_label>Sodium Oxybate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2.5g Sodium Oxybate administered during nap</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Zolpidem</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5mg Zolpidem administered during nap</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium Oxybate</intervention_name>
    <description>2.5g Sodium Oxybate administered during nap</description>
    <arm_group_label>Sodium Oxybate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Zolpidem</intervention_name>
    <description>5mg Zolpidem administered during nap</description>
    <arm_group_label>Zolpidem</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Placebo administered during nap</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  English-speaking individuals, half men and half women, and between the ages of 60 and
             75 years will be recruited. No ethnic group will be specifically excluded from study.
             All participants will be recruited from general San Diego Community. An education
             requirement of at least 12 years completed will be imposed, as education may affect
             performance on the cognitive task.

        Exclusion Criteria:

          -  Not having a regular sleep-wake schedule (defined as not meeting criteria listed above
             and/or a Horne-Ostberg Morningness-Eveningness Questionnaire score not between 31-69)

          -  Having a sleep disorder (reported or detected on the questionnaires)

          -  Any personal or immediate family (i.e., first degree relative) history of diagnosed
             significant psychopathology

          -  Personal history of head injury with loss of consciousness greater than 15 minutes or
             seizures

          -  History of substance dependence

          -  Current use of any psychotropic medications

          -  Any cardiac, respiratory or other medical condition which may affect cerebral
             metabolism

          -  Given the nature of the stimulus and its presentation, anyone with non-correctable
             vision and audition impairments will also be excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jen Kanady, BA</last_name>
    <phone>858-642-3192</phone>
    <email>jkanady@vapop.ucsd.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Laboratory for Sleep and Behavioral Neuroscience</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jen Kanady, BA</last_name>
      <phone>858-642-3192</phone>
      <email>jkanady@vapop.ucsd.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 15, 2008</study_first_submitted>
  <study_first_submitted_qc>October 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 16, 2008</study_first_posted>
  <last_update_submitted>October 15, 2008</last_update_submitted>
  <last_update_submitted_qc>October 15, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 16, 2008</last_update_posted>
  <responsible_party>
    <name_title>PI: Sara C. Mednick Ph.D.</name_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Zolpidem</mesh_term>
    <mesh_term>Sodium Oxybate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

